Yan Ma-Liang

West China Hospital Of Sichuan University Chengdu 610041 China +86-28-85423341 +86-28-85164167
Chengdu, 851641, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Correction: SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway.

Correction: SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway.

Journal: RSC advances

Published: July 21, 2026

Podocyte FFAR4 deficiency aggravated glomerular diseases and aging.

Podocyte FFAR4 deficiency aggravated glomerular diseases and aging.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 22, 2025

SKLB023 protects against inflammation and apoptosis in sepsis-associated acute kidney injury via the inhibition of toll-like receptor 4 signaling.

SKLB023 protects against inflammation and apoptosis in sepsis-associated acute kidney injury via the inhibition of toll-like receptor 4 signaling.

Journal: International immunopharmacology

Published: May 20, 2024

Chromodomain Y-like (CDYL) inhibition ameliorates acute kidney injury in mice by regulating tubular pyroptosis.

Chromodomain Y-like (CDYL) inhibition ameliorates acute kidney injury in mice by regulating tubular pyroptosis.

Journal: Acta pharmacologica Sinica

Published: April 18, 2024

Letter-to-the-editor on "Acetyl-CoA synthetase (ACSS2) does not generate butyryl- and crotonyl-CoA".

Letter-to-the-editor on "Acetyl-CoA synthetase (ACSS2) does not generate butyryl- and crotonyl-CoA".

Journal: Molecular metabolism

Published: March 07, 2024

Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence.

Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence.

Journal: Nature communications

Published: June 05, 2023

Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.

Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.

Journal: Acta pharmacologica Sinica

Published: April 09, 2023

Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.

Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.

Journal: Molecular cell

Published: February 22, 2023

Kidney fibrosis: from mechanisms to therapeutic medicines.

Kidney fibrosis: from mechanisms to therapeutic medicines.

Journal: Signal transduction and targeted therapy

Published: October 08, 2022

Novel post-translational modifications in the kidneys for human health and diseases.

Novel post-translational modifications in the kidneys for human health and diseases.

Journal: Life sciences

Published: August 22, 2022

Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.

Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.

Journal: Cell death & disease

Published: July 12, 2022

FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury.

FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury.

Journal: Signal transduction and targeted therapy

Published: June 14, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026